{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:05:04Z","timestamp":1791489904985,"version":"4.3.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/ajg.2010.455","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T10:40:38Z","timestamp":1292323238000},"page":"307-316","source":"Crossref","is-referenced-by-count":204,"title":["Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)"],"prefix":"10.14309","volume":"106","author":[{"given":"Sandeep Singh","family":"Sidhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omesh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bholeshwar Prashad","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajoo Singh","family":"Chhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder Kumar","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210210","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy- definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"R2-22-20210210","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2004.11.028","article-title":"Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations.","volume":"42","author":"Ortiz","year":"2005","journal-title":"J Hepatol"},{"key":"R3-22-20210210","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1586\/17474124.2.6.785","article-title":"Management options for minimal hepatic encephalopathy.","volume":"2","author":"Bajaj","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R4-22-20210210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2007-984576","article-title":"An algorithm for the management of hepatic encephalopathy.","volume":"27","author":"Mullen","year":"2007","journal-title":"Sem Liver Dis"},{"key":"R5-22-20210210","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11011-005-7919-z","article-title":"Attention, memory, and cognitive function in hepatic encephalopathy.","volume":"20","author":"Weissenborn","year":"2005","journal-title":"Metab Brain Dis"},{"key":"R6-22-20210210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/hep.510280108","article-title":"Subclinical hepatic encephalopathy impairs daily functioning.","volume":"28","author":"Groeneweg","year":"1998","journal-title":"Hepatology"},{"key":"R7-22-20210210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1011610427843","article-title":"Quality of life in cirrhotics with minimal hepatic encephalopathy.","volume":"16","author":"Schomerus","year":"2001","journal-title":"Metab Brain Dis"},{"key":"R8-22-20210210","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1111\/j.1572-0241.2001.04130.x","article-title":"Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.","volume":"96","author":"Romero-Gomez","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R9-22-20210210","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1440-1746.2001.02487.x","article-title":"Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis.","volume":"16","author":"Das","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"R10-22-20210210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1034\/j.1600-0676.2002.01431.x","article-title":"Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy.","volume":"22","author":"Saxena","year":"2002","journal-title":"Liver"},{"key":"R11-22-20210210","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.510290619","article-title":"Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests.","volume":"29","author":"Amodio","year":"1999","journal-title":"Hepatology"},{"key":"R12-22-20210210","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1572-0241.2008.01788.x","article-title":"Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.","volume":"103","author":"Sugimoto","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R13-22-20210210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/jcbfm.1991.67","article-title":"Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.","volume":"11","author":"Lockwood","year":"1991","journal-title":"J Cereb Blood Flow Metab"},{"key":"R14-22-20210210","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MEG.0b013e3282f3e6f5","article-title":"An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.","volume":"20","author":"Sharma","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R15-22-20210210","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","article-title":"Lactulose improves cognitive functions and health related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.","volume":"45","author":"Prasad","year":"2007","journal-title":"Hepatology"},{"key":"R16-22-20210210","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1023\/A:1005556826152","article-title":"Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy.","volume":"45","author":"Dhiman","year":"2000","journal-title":"Dig Dis Sci"},{"key":"R17-22-20210210","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.510260606","article-title":"Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy.","volume":"26","author":"Watanabe","year":"1997","journal-title":"Hepatology"},{"key":"R18-22-20210210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2036.1997.118289000.x","article-title":"Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy.","volume":"11","author":"Horsmans","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-22-20210210","first-page":"1126","article-title":"Effects of lactulose treatment on the course of subclinical hepatic encephalopathy in Chinese.","volume":"83","author":"Zeng","year":"2003","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R20-22-20210210","first-page":"325","article-title":"The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy.","volume":"6","author":"McClain","year":"1984","journal-title":"J Clin Gastroenterol"},{"key":"R21-22-20210210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0168-8278(89)90009-3","article-title":"Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients.","volume":"8","author":"Morgan","year":"1989","journal-title":"J Hepatol"},{"key":"R22-22-20210210","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0168-8278(05)80623-3","article-title":"Effects of long term administration of low dose lactitol in patients with cirrhosis but without overt encephalopathy.","volume":"21","author":"Salerno","year":"1994","journal-title":"J Hepatol"},{"key":"R23-22-20210210","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1572-0241.2008.01861.x","article-title":"Probiotic yogurt for the treatment of minimal hepatic encephalopathy.","volume":"103","author":"Bajaj","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R24-22-20210210","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"key":"R25-22-20210210","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","article-title":"Bifidobacterium longum with fructo-oligosaccharide (fos) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.","volume":"52","author":"Malaguarnera","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R26-22-20210210","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1007\/s10620-008-0238-6","article-title":"Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.","volume":"53","author":"Malaguarnera","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R27-22-20210210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/gut.24.1.53","article-title":"Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy.","volume":"24","author":"de Bruijn","year":"1983","journal-title":"Gut"},{"key":"R28-22-20210210","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0016-5085(85)80004-4","article-title":"Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double blind placebo-controlled crossover study.","volume":"88","author":"Egberts","year":"1985","journal-title":"Gastroenterology"},{"key":"R29-22-20210210","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/hep.21617","article-title":"Can we ignore minimal hepatic encephalopathy any longer?","volume":"45","author":"Qadri","year":"2007","journal-title":"Hepatology"},{"key":"R30-22-20210210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1345\/aph.1K436","article-title":"Rifaximin for treatment of hepatic encephalopathy.","volume":"43","author":"Maclayton","year":"2009","journal-title":"Ann Pharmacother"},{"key":"R31-22-20210210","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/MEG.0b013e328302f470","article-title":"Rifaximin vs. nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.","volume":"20","author":"Jiang","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R33-22-20210210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1440-1746.1995.tb01041.x","article-title":"Figure connection test: a universal test for assessment of mental state.","volume":"10","author":"Dhiman","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-22-20210210","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00005650-198108000-00001","article-title":"The sickness impact profile: development and final revision of a health status measure.","volume":"19","author":"Bergner","year":"1981","journal-title":"Med Care"},{"key":"R35-22-20210210","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1572-0241.2000.02265.x","article-title":"The prognostic significance of subclinical hepatic encephalopathy.","volume":"95","author":"Hartmann","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R36-22-20210210","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.20095","article-title":"Minimal hepatic encephalopathy impairs fitness to drive.","volume":"39","author":"Wein","year":"2004","journal-title":"Hepatology"},{"key":"R37-22-20210210","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/j.1572-0241.2007.01424.x","article-title":"Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations.","volume":"102","author":"Bajaj","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R38-22-20210210","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ajg.2009.7","article-title":"The effect of fatigue on driving skills in patients with hepatic encephalopathy.","volume":"104","author":"Bajaj","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R39-22-20210210","first-page":"175","article-title":"Rifaximin vs. neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.","volume":"23","author":"Pedretti","year":"1991","journal-title":"Ital J Gastroenterol"},{"key":"R40-22-20210210","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10620-006-9442-4","article-title":"Hospitalizations during the use of rifaximin vs. lactulose for the treatment of hepatic encephalopathy.","volume":"52","author":"Leevy","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R41-22-20210210","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy.","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"R42-22-20210210","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.21760","article-title":"Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.","volume":"46","author":"Kalaitzakis","year":"2007","journal-title":"Hepatology"},{"key":"R43-22-20210210","first-page":"255","article-title":"Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study.","volume":"50","author":"Tan","year":"2009","journal-title":"Singapore Med J"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2010455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010455","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201102000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:35:11Z","timestamp":1786541711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201102000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2010.455","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}